Ranking the importance of nuclear reactions for activation and transmutation events

Pathways-reduced analysis is one of the techniques used by the Fispact-II nuclear activation and transmutation software to study the sensitivity of the computed inventories to uncertainties in reaction cross-sections. Although deciding which pathways are most important is very helpful in for example determining which nuclear data would benefit from further refinement, pathways-reduced analysis need not necessarily define the most critical reaction, since one reaction may contribute to several different pathways. This work examines three different techniques for ranking reactions in their order of importance in determining the final inventory, comparing the pathways based metric (PBM), the direct method and one based on the Pearson correlation coefficient. Reasons why the PBM is to be preferred are presented.Comment: 30 pages, 10 figure

Variational Autoencoders for Feature Exploration and Malignancy Prediction of Lung Lesions

Lung cancer is responsible for 21% of cancer deaths in the UK and five-year survival rates are heavily influenced by the stage the cancer was identified at. Recent studies have demonstrated the capability of AI methods for accurate and early diagnosis of lung cancer from routine scans. However, this evidence has not translated into clinical practice with one barrier being a lack of interpretable models. This study investigates the application Variational Autoencoders (VAEs), a type of generative AI model, to lung cancer lesions. Proposed models were trained on lesions extracted from 3D CT scans in the LIDC-IDRI public dataset. Latent vector representations of 2D slices produced by the VAEs were explored through clustering to justify their quality and used in an MLP classifier model for lung cancer diagnosis, the best model achieved state-of-the-art metrics of AUC 0.98 and 93.1% accuracy. Cluster analysis shows the VAE latent space separates the dataset of malignant and benign lesions based on meaningful feature components including tumour size, shape, patient and malignancy class. We also include a comparative analysis of the standard Gaussian VAE (GVAE) and the more recent Dirichlet VAE (DirVAE), which replaces the prior with a Dirichlet distribution to encourage a more explainable latent space with disentangled feature representation. Finally, we demonstrate the potential for latent space traversals corresponding to clinically meaningful feature changes.Comment: 10 pages (main paper), 5 pages (references), 5 figures, 2 tables, work accepted for BMVC 202

A Block Krylov Method to Compute the Action of the Fréchet Derivative of a Matrix Function on a Vector with Applications to Condition Number Estimation

We design a block Krylov method to compute the action of the Fréchet derivative of a matrix function on a vector using only matrix-vector products, i.e., the derivative of $f(A)b$ when $A$ is subject to a perturbation in the direction $E$. The algorithm we derive is especially effective when the direction matrix $E$ in the derivative is of low rank, while there are no such restrictions on $A$. Our results and experiments are focused mainly on Fréchet derivatives with rank 1 direction matrices. Our analysis applies to all functions with a power series expansion convergent on a subdomain of the complex plane which, in particular, includes the matrix exponential. We perform an a priori error analysis of our algorithm to obtain rigorous stopping criteria. Furthermore, we show how our algorithm can be used to estimate the 2-norm condition number of $f(A)b$ efficiently. Our numerical experiments show that our new algorithm for computing the action of a Fréchet derivative typically requires a small number of iterations to converge and (particularly for single and half precision accuracy) is significantly faster than alternative algorithms. When applied to condition number estimation, our experiments show that the resulting algorithm can detect ill-conditioned problems that are undetected by competing algorithms

The discerning eye of computer vision: can it measure Parkinson's finger tap bradykinesia?

Objective: The worldwide prevalence of Parkinson's disease is increasing. There is urgent need for new tools to objectively measure the condition. Existing methods to record the cardinal motor feature of the condition, bradykinesia, using wearable sensors or smartphone apps have not reached large-scale, routine use. We evaluate new computer vision (artificial intelligence) technology, DeepLabCut, as a contactless method to quantify measures related to Parkinson's bradykinesia from smartphone videos of finger tapping. Methods: Standard smartphone video recordings of 133 hands performing finger tapping (39 idiopathic Parkinson's patients and 30 controls) were tracked on a frame-by-frame basis with DeepLabCut. Objective computer measures of tapping speed, amplitude and rhythm were correlated with clinical ratings made by 22 movement disorder neurologists using the Modified Bradykinesia Rating Scale (MBRS) and Movement Disorder Society revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS). Results: DeepLabCut reliably tracked and measured finger tapping in standard smartphone video. Computer measures correlated well with clinical ratings of bradykinesia (Spearman coefficients): -0.74 speed, 0.66 amplitude, -0.65 rhythm for MBRS; -0.56 speed, 0.61 amplitude, -0.50 rhythm for MDS-UPDRS; -0.69 combined for MDS-UPDRS. All p Conclusion: New computer vision software, DeepLabCut, can quantify three measures related to Parkinson's bradykinesia from smartphone videos of finger tapping. Objective 'contactless' measures of standard clinical examinations were not previously possible with wearable sensors (accelerometers, gyroscopes, infrared markers). DeepLabCut requires only conventional video recording of clinical examination and is entirely 'contactless'. This next generation technology holds potential for Parkinson's and other neurological disorders with altered movements

Supervised classification of bradykinesia for Parkinson’s disease diagnosis from smartphone videos

Slowness of movement, known as bradykinesia, in an important early symptom of Parkinson’s disease. This symptom is currently assessed subjectively by clinical experts. However, expert assessment has been shown to be subject to inter-rater variability. We propose a low-cost, contactless system using smartphone videos to automatically determine the presence of bradykinesia. Using 70 videos recorded in a pilot study, we predict the presence of bradykinesia with an estimated test accuracy of 0.79 and the presence of Parkinson’s disease diagnosis with estimated test accuracy 0.63. Even on a small set of pilot data this accuracy is comparable to that recorded by blinded human experts

Supervised classification of bradykinesia for Parkinson's disease diagnosis from smartphone videos

Slowness of movement, known as bradykinesia, is an important early symptom of Parkinson's disease. This symptom is currently assessed subjectively by clinical experts. However, expert assessment has been shown to be subject to inter-rater variability. We propose a low-cost, contactless system using smarthphone videos to automatically determine the presence of bradykinesia. Using 70 videos recorded in a pilot study, we predicted the presence of bradykinesia with an estimated test accuracy of 0.79 and the presence of Parkinson's disease with estimated test accuracy 0.63. Even on a small set of pilot data this accuracy is comparable to that recorded by blinded human experts

To the emergency room and back again : circular healthcare pathways for acute functional neurological disorders

Background and objectives: Studies of Functional Neurological Disorders (FND) are usually outpatient-based. To inform service development, we aimed to describe patient pathways through healthcare events, and factors affecting risk of emergency department (ED) reattendance, for people presenting acutely with FND. Methods: Acute neurology/stroke teams at a UK city hospital were contacted regularly over 8 months to log FND referrals. Electronic documentation was then reviewed for hospital healthcare events over the preceding 8 years. Patient pathways through healthcare events over time were mapped, and mixed effects logistic regression was performed for risk of ED reattendance within 1 year. Results: In 8 months, 212 patients presented acutely with an initial referral suggesting FND. 20% had subsequent alternative diagnoses, but 162 patients were classified from documentation review as possible (17%), probable (28%) or definite (55%) FND. In the preceding 8 years, these 162 patients had 563 ED attendances and 1693 inpatient nights with functional symptoms, but only 26% were referred for psychological therapy, only 66% had a documented diagnosis, and care pathways looped around ED. Three better practice pathway steps were each associated with lower risk of subsequent ED reattendance: documented FND diagnosis (OR = 0.32, p = 0.004), referral to clinical psychology (OR = 0.35, p = 0.04) and outpatient neurology follow-up (OR = 0.25, p < 0.001). Conclusion: People that present acutely to a UK city hospital with FND tend to follow looping pathways through hospital healthcare events, centred around ED, with low rates of documented diagnosis and referral for psychological therapy. When better practice occurs, it is associated with lower risk of ED reattendance

Taylor's theorem for matrix functions with applications to condition number estimation

We derive an explicit formula for the remainder term of a Taylor polynomial of a matrix function. This formula generalizes a known result for the remainder of the Taylor polynomial for an analytic function of a complex scalar. We investigate some consequences of this result, which culminate in new upper bounds for the level-1 and level-2 condition numbers of a matrix function in terms of the pseudospectrum of the matrix. Numerical experiments show that, although the bounds can be pessimistic, they can be computed much faster than the standard methods. This makes the upper bounds ideal for a quick estimation of the condition number whilst a more accurate (and expensive) method can be used if further accuracy is required. They are also easily applicable to more complicated matrix functions for which no specialized condition number estimators are currently available

Development and external validation of the eFalls tool: a multivariable prediction model for the risk of ED attendance or hospitalisation with a fall or fracture in older adults.

Falls are common in older adults and can devastate personal independence through injury such as fracture and fear of future falls. Methods to identify people for falls prevention interventions are currently limited, with high risks of bias in published prediction models. We have developed and externally validated the eFalls prediction model using routinely collected primary care electronic health records (EHR) to predict risk of emergency department attendance/hospitalisation with fall or fracture within 1 year. Data comprised two independent, retrospective cohorts of adults aged ≥65 years: the population of Wales, from the Secure Anonymised Information Linkage Databank (model development); the population of Bradford and Airedale, England, from Connected Bradford (external validation). Predictors included electronic frailty index components, supplemented with variables informed by literature reviews and clinical expertise. Fall/fracture risk was modelled using multivariable logistic regression with a Least Absolute Shrinkage and Selection Operator penalty. Predictive performance was assessed through calibration, discrimination and clinical utility. Apparent, internal-external cross-validation and external validation performance were assessed across general practices and in clinically relevant subgroups. The model's discrimination performance (c-statistic) was 0.72 (95% confidence interval, CI: 0.68 to 0.76) on internal-external cross-validation and 0.82 (95% CI: 0.80 to 0.83) on external validation. Calibration was variable across practices, with some over-prediction in the validation population (calibration-in-the-large, -0.87; 95% CI: -0.96 to -0.78). Clinical utility on external validation was improved after recalibration. The eFalls prediction model shows good performance and could support proactive stratification for falls prevention services if appropriately embedded into primary care EHR systems. [Abstract copyright: © The Author(s) 2024. Published by Oxford University Press on behalf of the British Geriatrics Society.